www.wsj.com // Created: 1d // Updated: 5hr
News - Politics Share
The Cato Institute’s Michael F. Cannon writes that patients
with costly conditions like MS are seeing coverage cut.
By
Michael F. Cannon
Republicans are nervous about repealing ObamaCare’s supposed
ban on discrimination against patients with pre-existing conditions. But a new
study by Harvard and the University of Texas-Austin finds those rules penalize
high-quality coverage for the sick, reward insurers who slash coverage for the
sick, and leave patients unable to obtain adequate insurance.
The researchers estimate a patient with multiple sclerosis,
for example, might file $61,000 in claims. ObamaCare’s rules let MS patients
buy coverage for far less, forcing insurers to take a loss on every MS patient.
That creates “an incentive to avoid enrolling people who are in worse health”
by making policies “unattractive to people with expensive health conditions,”
the Kaiser Family Foundation explains.
To mitigate that perverse incentive, ObamaCare lobs all
manner of taxpayer subsidies at insurers. Yet the researchers find insurers
still receive just $47,000 in revenue per MS patient—a $14,000 loss per
patient.
Predictably, that triggers a race to the bottom. Each year,
whichever insurer offers the best MS coverage attracts the most MS patients and
racks up the most losses. Insurers that offer high-quality coverage either
leave the market, as many have, or slash their coverage. Let’s call those losses
what
they are: penalties for offering high-quality coverage.
The result is lower-quality coverage—for MS, rheumatoid
arthritis, infertility and other expensive conditions. The researchers find
these patients face higher cost-sharing (even for inexpensive drugs), more
prior-authorization requirements, more mandatory substitutions, and often no
coverage for the drugs they need, so that consumers “cannot be adequately
insured.”
Independent Institute Senior Fellow John Goodman on the
Republican Party’s debate over healthcare reform. Photo credit: Reuters.
The study also corroborates reports that these rules are
subjecting patients to higher deductibles and cost-sharing across the board,
narrow networks that exclude leading cancer centers, inaccurate provider
directories, and opaque cost-sharing. A coalition of 150 patient groups
complains this government-fostered race to the bottom “completely undermines
the goal of the ACA.”
It doesn’t have to be like this. Employer plans offer drug
coverage more comprehensive and sustainable than ObamaCare. The pre-2014
individual market made comprehensive coverage even more secure: High-cost
patients were less likely to lose coverage than similar enrollees in employer
plans. The individual market created innovative products like “pre-existing
conditions insurance” that—for one-fifth the cost of health insurance—gave the
uninsured the right to enroll in coverage at healthy-person premiums if they
developed expensive conditions.
If anything, Republicans should fear not repealing
ObamaCare’s pre-existing-conditions rules. The Congressional Budget Office
predicts a partial repeal would wipe out the individual market and cause nine
million to lose coverage unnecessarily. And contrary to conventional wisdom,
the consequences of those rules are wildly unpopular. In a new Cato
Institute/YouGov poll, 63% of respondents initially supported ObamaCare’s
pre-existing-condition rules. That dropped to 31%—with 60% opposition—when they
were told of the impact on quality.
Republicans can’t keep their promise to repeal ObamaCare and
improve access for the sick without repealing the ACA’s penalties on
high-quality coverage.
Mr. Cannon is director of health policy studies at the
Cato Institute.
Tags: The Wall Street Journal, Cato Institute and Michael F. Cannon
Tags: The Wall Street Journal, Cato Institute and Michael F. Cannon
No comments:
Post a Comment